187 related articles for article (PubMed ID: 35084993)
1. Diagnosis and Treatment of
Lee YC; Dore MP; Graham DY
Annu Rev Med; 2022 Jan; 73():183-195. PubMed ID: 35084993
[TBL] [Abstract][Full Text] [Related]
2. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
3. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Guevara B; Cogdill AG
Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
[TBL] [Abstract][Full Text] [Related]
4. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
5. One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
Perng CL; Kim JG; El-Zimaity HM; Osato MS; Graham DY
Dig Dis Sci; 1998 Mar; 43(3):464-7. PubMed ID: 9539638
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016.
Fiorini G; Zullo A; Saracino IM; Pavoni M; Vaira D
Scand J Gastroenterol; 2018 Jun; 53(6):661-664. PubMed ID: 29688095
[TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of Helicobacter pylori in Iceland.
Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
[TBL] [Abstract][Full Text] [Related]
12. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Branquinho D; Almeida N; Gregório C; Cabral JE; Casela A; Donato MM; Tomé L
BMC Gastroenterol; 2017 Feb; 17(1):31. PubMed ID: 28202013
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori antimicrobial resistance in a pediatric population.
Silva GM; Silva HM; Nascimento J; Gonçalves JP; Pereira F; Lima R
Helicobacter; 2018 Oct; 23(5):e12528. PubMed ID: 30091503
[TBL] [Abstract][Full Text] [Related]
14. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
16. Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains.
Gatta L; Scarpignato C; Fiorini G; Belsey J; Saracino IM; Ricci C; Vaira D
Aliment Pharmacol Ther; 2018 May; 47(9):1261-1269. PubMed ID: 29536561
[TBL] [Abstract][Full Text] [Related]
17. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and management of H. pylori infection in Singapore.
Chew CA; Lye TF; Ang D; Ang TL
Singapore Med J; 2017 May; 58(5):234-240. PubMed ID: 28536725
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
[TBL] [Abstract][Full Text] [Related]
20. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
